Effects of febuxostat versus allopurinol in patients with elevated serum uric acid levels, chronic gout: A literature review
Labbad, Ziad G.
Permanent link to this recordhttp://hdl.handle.net/20.500.12613/9048
MetadataShow full item record
AbstractGout is one of the most common etiologies of inflammatory monoarticular arthritis. Recent literature is reviewed to compare a novel advancement in chronic gout medication, febuxostat, to its counterpart allopurinol, through the identification of significant findings and improvements. Literature review concluded that febuxostat serves as a viable alternative when compared to allopurinol.
CitationLove E, Mergelsberg H, Kellmyer A, Jeganathan J, Isa F, McGuire J, Khan K, Labbad Z. Effects of febuxostat versus allopurinol in patients with elevated serum uric acid levels, chronic gout: A literature review. Journal of the International Foot & Ankle Foundation [Internet]. 2022 Mar 8;1(3). Available from: https://internationalfootankle.org/journal/index.php/JIFAF/article/view/12 doi: 10.55067/jifaf.v1i3.12
Citation to related workInternational Foot & Ankle Foundation
Has partThe Journal of the International Foot & Ankle Foundation, Vol. 1, No. 3
ADA complianceFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact firstname.lastname@example.org
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs CC BY-NC-ND